| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▼ | 1.36▼ | 1.36▼ | 1.35▼ | 1.44▼ |
| MA10 | 1.36▼ | 1.37▼ | 1.37▼ | 1.41▼ | 1.78▼ |
| MA20 | 1.36▼ | 1.38▼ | 1.35▼ | 1.47▼ | 1.64▼ |
| MA50 | 1.37▼ | 1.35▲ | 1.39▼ | 1.88▼ | 1.64▼ |
| MA100 | 1.37▼ | 1.40▼ | 1.44▼ | 1.59▼ | 2.11▼ |
| MA200 | 1.34▲ | 1.45▼ | 1.63▼ | 1.60▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.004▼ | 0.002▲ | 0.000▼ | -0.063▼ |
| RSI | 30.629▼ | 44.882▼ | 45.166▼ | 36.703▼ | 43.465▼ |
| STOCH | 37.500 | 21.268 | 30.632 | 24.757 | 12.824▼ |
| WILL %R | -75.000 | -92.857▼ | -76.471▼ | -77.419▼ | -96.354▼ |
| CCI | -228.635▼ | -128.256▼ | -106.354▼ | -89.749 | -95.689 |
|
Tuesday, March 31, 2026 06:32 AM
Potential breakthrough therapeutic targets $50B+ global immunotherapy market1CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, ...
|
|
Wednesday, March 04, 2026 08:57 PM
Financing included participation by healthcare-dedicated investors alongsideexisting shareholders CHICAGO, IL, March 04, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA ...
|
|
Wednesday, March 04, 2026 02:13 PM
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 1.41 | 1.43 | 1.34 | 1.34 | 384,468 |
| 31/03/26 | 1.33 | 1.42 | 1.32 | 1.40 | 1,032,053 |
| 30/03/26 | 1.34 | 1.37 | 1.27 | 1.31 | 538,315 |
| 27/03/26 | 1.41 | 1.48 | 1.29 | 1.31 | 2,488,985 |
| 26/03/26 | 1.47 | 1.475 | 1.37 | 1.38 | 1,253,154 |
| 25/03/26 | 1.44 | 1.51 | 1.43 | 1.47 | 484,429 |
| 24/03/26 | 1.49 | 1.50 | 1.44 | 1.44 | 262,417 |
| 23/03/26 | 1.46 | 1.51 | 1.44 | 1.49 | 381,009 |
| 20/03/26 | 1.45 | 1.4999 | 1.41 | 1.46 | 646,418 |
| 19/03/26 | 1.46 | 1.51 | 1.43 | 1.50 | 434,545 |
|
|
||||
|
|
||||
|
|